RSS Feed
Search Ask-Cato.com
Tags
adverse events biologics biosimilar biotech cancer Cato BioVentures Cato Research CDER clinical investigator clinical research clinical trials CMC conference CROs DIA drug development eCTD efficacy FDA funding GlobalSubmit guidance Health Canada IND in vitro diagnostics labeling manufacturing marketing application medical devices NDA NIH nonclinical research oncology Phase 1 Phase 2 postmarketing protocol regulatory affairs safety statistical analysis toxicology transparency venture capital warning letters webinarCategories
- Clinical Trials (52)
- Conferences and Meetings (34)
- eCTD (26)
- FDA (71)
- Guest Posts (5)
- Health Canada (6)
- Industry News (56)
- Project Management (1)
- Publications (7)
- Regulatory Strategy (36)
- Social Media (6)
- Statistics (9)
- Uncategorized (1)
- Venture Capital (10)
- Webinars (24)
Tag Archives: outsourcing
CRO Industry Trends
The past few years have challenged Clinical Research Organizations (CROs) to adjust their business models to meet the changing needs of pharmaceutical and biotech companies. Most CROs saw disappointing 2009 earnings, especially those focused on early stage and nonclinical research, says Scrip Clinical Research, but many mid-sized CROs saw growth in 2010. Whether CROs will be able to sustain growth in 2011 remains unclear. What we do know is that the most successful ones will be those that embrace the three major industry trends – globalization, an increased use of preferred provider relationships, and a greater willingness to invest in new technology. Continue reading
Posted in Industry News
Tagged biotech, clinical trials, CROs, CTMS, EDC, outsourcing, vendors
1 Comment
Vendor Selection – All that Glitters is Not Gold
One of the most important, and difficult, decisions a company has to make is selecting the right contract research organization (CRO) for outsourcing its nonclinical, manufacturing, clinical and regulatory activities. Several variables determine what makes a good outsourcing partner – … Continue reading
Posted in Clinical Trials, Regulatory Strategy
Tagged biotech, clinical trials, CMC, CROs, drug development, funding, IND, manufacturing, nonclinical research, outsourcing, pre-IND, regulatory affairs
Comments Off
Give Your Scientists an Edge – Partner with a CRO!
Image via Wikipedia In the fast paced R&D world, every biotech is looking for an edge to keep them ahead of their competitors and to help them achieve their goal of either getting a drug to human clinical trials or … Continue reading
Posted in Regulatory Strategy, Venture Capital
Tagged biotech, clinical trials, drug development, nonclinical research, outsourcing, venture capital
Comments Off
Tech Council of Maryland BioBreakfast Series
The Tech Council of Maryland (TCM), Maryland’s largest technology trade association, brings its 500 plus members access to technology industry leaders in Maryland, DC and Virginia. MdBio, a division of the TCM, seeks to unify, empower and advance Maryland’s bioscience … Continue reading
Posted in Conferences and Meetings
Tagged BioBreakfast, Maryland, MdBio, outsourcing, panel discussion, Tech Council of Maryland
1 Comment
Regulatory Affairs Workload Increasing
I would rather have a big burden and a strong back, than a weak back and a caddy to carry life’s luggage – Elbert Hubbard I don’t know if you follow the Tufts Center for the Study of Drug Development … Continue reading
Posted in Industry News
Tagged clinical research, clinical trials, contract employees, NDA, outsourcing, protocol, regulatory affairs, strategic insourcing, Tufts
1 Comment
